Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

WDR7 Inhibitors

WDR7 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the WDR7 protein, a member of the WD repeat-containing protein family. WDR7, like other proteins in this family, contains WD40 repeat domains that are crucial for mediating protein-protein interactions and facilitating the formation of multiprotein complexes. These complexes play essential roles in various cellular processes, including vesicular trafficking, signal transduction, and organelle organization. WDR7 is particularly involved in regulating membrane dynamics and intracellular transport, likely through its interaction with proteins that control vesicle formation and movement. Inhibiting WDR7 disrupts these processes, which can lead to alterations in cellular transport and communication pathways that are vital for maintaining cellular homeostasis.

The mechanism of WDR7 inhibitors generally involves binding to the WD40 repeat domains or other functional regions of the protein, preventing WDR7 from interacting with its target proteins and carrying out its normal functions. This disruption can have downstream effects on processes like endosome maturation, vesicle recycling, and organelle positioning, as WDR7 is thought to be a key player in these pathways. By inhibiting WDR7, researchers can study its specific role in intracellular trafficking and how its modulation affects the broader molecular systems that rely on vesicle-mediated transport. These inhibitors are valuable tools for exploring how WD repeat-containing proteins contribute to the coordination of complex cellular mechanisms, offering insights into the regulatory networks that control membrane dynamics, protein sorting, and overall cellular organization. Understanding these interactions helps to clarify the biological significance of WDR7 in maintaining the efficiency and balance of intracellular processes.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Inhibits protein transport from the ER to the Golgi, potentially impacting WDR7-related trafficking.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

PI3K inhibitor, could influence signaling pathways where WDR7 is involved.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$89.00
44
(2)

Inhibits dynamin, affecting vesicle scission, potentially impacting WDR7's role in membrane dynamics.

YM201636

371942-69-7sc-204193
5 mg
$217.00
6
(1)

Inhibits PIKfyve, affecting phosphoinositide signaling involved in membrane trafficking.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Another PI3K inhibitor, potentially affecting signaling pathways related to WDR7.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$155.00
$525.00
(1)

Disrupts Golgi function, potentially influencing WDR7's role in membrane trafficking.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$59.00
$85.00
$143.00
$247.00
38
(2)

Disrupts microtubule polymerization, which could indirectly affect WDR7 function.

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$165.00
$486.00
64
(4)

Inhibits actin polymerization, potentially impacting WDR7's interactions with the cytoskeleton.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Tyrosine kinase inhibitor, could affect signaling pathways involving WDR7.

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$41.00
$74.00
$221.00
$247.00
$738.00
$1220.00
39
(2)

Stabilizes microtubules, possibly influencing cellular processes where WDR7 is involved.